ARTICLE | Clinical News
Alliance to continue Oxygent development
March 13, 2001 8:00 AM UTC
ALLP and partner Baxter (BAX) plan to continue development of ALLP's Oxygent perflubron blood substitute based on preliminary analysis of Phase III safety data that showed no evidence linking the prod...